News for Amplitude Healthcare Acquisition Corporation (AMHC)

REDWOOD CITY, Calif., Feb. 17, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on developing...

Read Brokers Issue Forecasts for Jasper Therapeutics Inc’s FY2022 Earnings (NASDAQ:JSPR) at ETF Daily News

Read Jasper Therapeutics Inc (NASDAQ:JSPR) Expected to Announce Earnings of -$0.28 Per Share at ETF Daily News

Read Jasper Therapeutics (NASDAQ:JSPR) & Sorrento Therapeutics (NASDAQ:SRNE) Critical Contrast at ETF Daily News

Read Cantor Fitzgerald Begins Coverage on Jasper Therapeutics (NASDAQ:JSPR) at ETF Daily News

Read Jasper Therapeutics (NASDAQ:JSPR) PT Lowered to $10.00 at ETF Daily News

Wall Street analysts expect Jasper Therapeutics Inc (NASDAQ:JSPR) to post earnings of ($0.28) per share for the current fiscal quarter, according to Zacks. Zero analysts have issued estimates for Jasper Therapeutics’ earnings, with the highest EPS estimate coming in at ($0.27) and the lowest estimate coming in at ($0.29). The business is expected to issue […]

REDWOOD CITY, Calif., Nov. 12, 2021 -- Jasper Therapeutics, Inc. , a biotechnology company focused on hematopoietic cell transplant therapies, today announced results for the quarter ended... | November 12, 2021

Jasper Therapeutics Inc (NASDAQ:JSPR) is trading lower Thursday amid profit taking after the stock rallied roughly 120% on Wednesday. Jasper...

Combined company expected to begin trading on the Nasdaq Global Select Market under “JSPR” and “JSPRW” on or about September 27, 2021 ... | September 24, 2021